David J. Gallacher

Experimentally calibrated population of models predicts and explains intersubject variability in cardiac cellular electrophysiology

Oliver J. Britton, Alfonso Bueno‐Orovio, Karel Van Ammel et al. · Proceedings of the National Academy of Sciences · 2013 · 331 citations · Full text

Life Sciences, Cardiology, Physiology +16

Predicting drug‐induced changes in QT interval and arrhythmias: QT‐shortening drugs point to gaps in the ICHS7B Guidelines

Hua Rong Lu, Eddy Vlaminckx, An N. Hermans et al. · British Journal of Pharmacology · 2008 · 130 citations · Full text

Medicine, Cardiology, Pharmacology +17

High throughput measurement of Ca2+ dynamics for drug risk assessment in human stem cell-derived cardiomyocytes by kinetic image cytometry

Fabio Cerignoli, David Charlot, Ross Whittaker et al. · Journal of Pharmacological and Toxicological Methods · 2012 · 129 citations · Full text

Natural Sciences, Biophysics, Cell Biology +15

A new biomarker – index of Cardiac Electrophysiological Balance (iCEB) – plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs)

Hua Rong Lu, Gan‐Xin Yan, David J. Gallacher · Journal of Pharmacological and Toxicological Methods · 2013 · 128 citations

Medicine, Cardiology, Pharmacology +15

Evaluation of Index of Cardio‐Electrophysiological Balance (iCEB) as a New Biomarker for the Identification of Patients at Increased Arrhythmic Risk

Tomas Robyns, Hua Rong Lu, David J. Gallacher et al. · Annals of Noninvasive Electrocardiology · 2015 · 116 citations · Full text

Medicine, Cardiology, Pharmacology +17